Tirapazamine

Tirapazamine is a high-purity Active Pharmaceutical Ingredient supplied by Mediocon Inc conforming to IP / BP / EP / USP specifications. Manufactured at our GMP-certified facility in Aurangabad, Maharashtra, India.

Tirapazamine is a bioreductive prodrug that is selectively toxic to hypoxic tumour cells. It is activated under low-oxygen conditions to generate cytotoxic radical species causing DNA strand breaks, making it an important investigational anticancer agent.

Key Features

• High-purity pharmaceutical grade API
• IP / BP / EP / USP compliant
• Full CoA and MSDS documentation
• GMP certified manufacturing facility

Applications

• Hypoxic tumour cell cytotoxicity
• Combination cancer chemotherapy
• Head and neck cancer research
• Bioreductive anticancer research

Why Choose Mediocon

• ISO 9001:2015 & GMP certified manufacturing
• Consistent batch-to-batch quality with full CoA
• Export-ready documentation: COO, MSDS, DMF
• Flexible MOQ for both R&D and commercial scale
• Dedicated QA support for regulatory filings